增加生物医学研究监管和管理的价值和减少浪费
Rustam Al-Shahi Salman1, Elaine Beller2, Jonathan Kagan3
1Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Lancet (London, England)
|January 14, 2014
概括
简化生物医学研究监管和管理可以最大限度地减少浪费. 建议侧重于适当的监督,协调的流程,高效的研究进行,并将研究纳入临床实践.
科学领域:
- 生物医学研究生物医学研究
- 卫生政策 卫生政策
- 研究管理研究管理管理
背景情况:
- 生物医学研究的监管和治理可能是繁重的,并且与风险不成比例.
- 研究过程的管理效率低下导致浪费,特别是影响参与者的招聘和保留.
- 当前的监管框架可能会无意中损害患者和公共利益.
研究的目的:
- 确定生物医学研究监管,治理和管理中的废物来源.
- 为减少浪费和提高研究效率提出建议.
- 倡导对研究监督采取更为比例和简化的方式.
主要方法:
- 分析生物医学研究现有的监管和治理框架.
- 确定研究行为中的低效率,包括参与者招聘,保留和数据管理.
- 根据专家的共识和最佳实践制定建议.
主要成果:
- 生物医学研究中的浪费源于监管负担,治理效率低下和程序管理问题.
- 为了减少浪费,提出了四个关键建议:监管机构的影响,简化/协调法规,高效的研究行为和将其纳入临床实践.
- 对遵守指标的监测和发布对于问责制至关重要.
结论:
- 尽量减少生物医学研究中的浪费需要涉及监管机构,政策制定者,研究人员和医疗保健系统的多方面的方法.
- 简化法规和改善研究管理对于高效和有效的生物医学研究至关重要.
- 将研究纳入临床实践,并确保相称的监督,将增强患者和公共利益.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Ethics in Research
23.7K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248


